The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults.

Comirnaty (tozinameran) - Pfizer, BioNTech

Covovax (NVX-CoV2373) - Novavax, Serum Institute of India

DoCo-Pro-RBD-1+MF59 - The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Monash University

http://www.ncbi.nlm.nih.gov/pubmed/42700749

C C Blyth; C Foulis; G Salama; H Marshall; J A Marsh; K L Flanagan; K Subbarao; M C Tjiam; M Dymock; M J Estcourt; M Plebanski; Mckenzie A; McLeod C; P Richmond; P Williams; R B Thornton; S N Faust; S Nicholson; T L Snelling; U Wadia; Z Ellis

Sep 6, 2026